IBDEI0WU ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14801,1,3,0)
 ;;=3^Monoplegia Upper Limb after CVA-Rt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,14801,1,4,0)
 ;;=4^I69.333
 ;;^UTILITY(U,$J,358.3,14801,2)
 ;;=^5007498
 ;;^UTILITY(U,$J,358.3,14802,0)
 ;;=I69.334^^58^707^39
 ;;^UTILITY(U,$J,358.3,14802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14802,1,3,0)
 ;;=3^Monoplegia Upper Limb after CVA-Lt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,14802,1,4,0)
 ;;=4^I69.334
 ;;^UTILITY(U,$J,358.3,14802,2)
 ;;=^5007499
 ;;^UTILITY(U,$J,358.3,14803,0)
 ;;=I69.341^^58^707^36
 ;;^UTILITY(U,$J,358.3,14803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14803,1,3,0)
 ;;=3^Monoplegia Lower Limb after CVA-Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,14803,1,4,0)
 ;;=4^I69.341
 ;;^UTILITY(U,$J,358.3,14803,2)
 ;;=^5007501
 ;;^UTILITY(U,$J,358.3,14804,0)
 ;;=I69.342^^58^707^34
 ;;^UTILITY(U,$J,358.3,14804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14804,1,3,0)
 ;;=3^Monoplegia Lower Limb after CVA-Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,14804,1,4,0)
 ;;=4^I69.342
 ;;^UTILITY(U,$J,358.3,14804,2)
 ;;=^5133575
 ;;^UTILITY(U,$J,358.3,14805,0)
 ;;=I69.343^^58^707^37
 ;;^UTILITY(U,$J,358.3,14805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14805,1,3,0)
 ;;=3^Monoplegia Lower Limb after CVA-Rt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,14805,1,4,0)
 ;;=4^I69.343
 ;;^UTILITY(U,$J,358.3,14805,2)
 ;;=^5007502
 ;;^UTILITY(U,$J,358.3,14806,0)
 ;;=I69.344^^58^707^35
 ;;^UTILITY(U,$J,358.3,14806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14806,1,3,0)
 ;;=3^Monoplegia Lower Limb after CVA-Lt Non-Dominant Side
 ;;^UTILITY(U,$J,358.3,14806,1,4,0)
 ;;=4^I69.344
 ;;^UTILITY(U,$J,358.3,14806,2)
 ;;=^5133576
 ;;^UTILITY(U,$J,358.3,14807,0)
 ;;=I25.10^^58^708^7
 ;;^UTILITY(U,$J,358.3,14807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14807,1,3,0)
 ;;=3^Athscl Hrt Dis of Nat Cor Artery w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,14807,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,14807,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,14808,0)
 ;;=J44.1^^58^708^16
 ;;^UTILITY(U,$J,358.3,14808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14808,1,3,0)
 ;;=3^COPD w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,14808,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,14808,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,14809,0)
 ;;=J44.9^^58^708^18
 ;;^UTILITY(U,$J,358.3,14809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14809,1,3,0)
 ;;=3^COPD, unspecified
 ;;^UTILITY(U,$J,358.3,14809,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,14809,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,14810,0)
 ;;=Z98.61^^58^708^20
 ;;^UTILITY(U,$J,358.3,14810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14810,1,3,0)
 ;;=3^Coronary angioplasty status
 ;;^UTILITY(U,$J,358.3,14810,1,4,0)
 ;;=4^Z98.61
 ;;^UTILITY(U,$J,358.3,14810,2)
 ;;=^5063742
 ;;^UTILITY(U,$J,358.3,14811,0)
 ;;=J43.9^^58^708^21
 ;;^UTILITY(U,$J,358.3,14811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14811,1,3,0)
 ;;=3^Emphysema, unspecified
 ;;^UTILITY(U,$J,358.3,14811,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,14811,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,14812,0)
 ;;=Z82.49^^58^708^23
 ;;^UTILITY(U,$J,358.3,14812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14812,1,3,0)
 ;;=3^Family Hx of Ischemic Hrt Dis/Oth Circ System Dis
 ;;^UTILITY(U,$J,358.3,14812,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,14812,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,14813,0)
 ;;=I50.9^^58^708^24
